These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 20197136)
1. The potential of 3',5'-cyclic diguanylic acid (c-di-GMP) as an effective vaccine adjuvant. Chen W; Kuolee R; Yan H Vaccine; 2010 Apr; 28(18):3080-5. PubMed ID: 20197136 [TBL] [Abstract][Full Text] [Related]
2. The effect of c-di-GMP (3'-5'-cyclic diguanylic acid) on the biofilm formation and adherence of Streptococcus mutans. Yan W; Qu T; Zhao H; Su L; Yu Q; Gao J; Wu B Microbiol Res; 2010 Feb; 165(2):87-96. PubMed ID: 19186044 [TBL] [Abstract][Full Text] [Related]
3. 3',5'-Cyclic diguanylic acid: a small nucleotide that makes big impacts. Yan H; Chen W Chem Soc Rev; 2010 Aug; 39(8):2914-24. PubMed ID: 20577685 [TBL] [Abstract][Full Text] [Related]
4. c-di-GMP-mediated regulation of virulence and biofilm formation. Cotter PA; Stibitz S Curr Opin Microbiol; 2007 Feb; 10(1):17-23. PubMed ID: 17208514 [TBL] [Abstract][Full Text] [Related]
5. 3',5'-Cyclic diguanylic acid (c-di-GMP) inhibits basal and growth factor-stimulated human colon cancer cell proliferation. Karaolis DK; Cheng K; Lipsky M; Elnabawi A; Catalano J; Hyodo M; Hayakawa Y; Raufman JP Biochem Biophys Res Commun; 2005 Apr; 329(1):40-5. PubMed ID: 15721270 [TBL] [Abstract][Full Text] [Related]
6. Cyclic di-GMP signalling controls virulence properties of Salmonella enterica serovar Typhimurium at the mucosal lining. Lamprokostopoulou A; Monteiro C; Rhen M; Römling U Environ Microbiol; 2010 Jan; 12(1):40-53. PubMed ID: 19691499 [TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of bis-carbamate analogs of cyclic bis-(3'-5')-diguanylic acid (c-di-GMP) and the acyclic dimer PGPG. Kline T; Jackson SR; Deng W; Verlinde CL; Miller SI Nucleosides Nucleotides Nucleic Acids; 2008 Dec; 27(12):1282-300. PubMed ID: 19003573 [TBL] [Abstract][Full Text] [Related]
8. Cyclic di-GMP as a second messenger. Römling U; Amikam D Curr Opin Microbiol; 2006 Apr; 9(2):218-28. PubMed ID: 16530465 [TBL] [Abstract][Full Text] [Related]
9. Bacterial c-di-GMP is an immunostimulatory molecule. Karaolis DK; Means TK; Yang D; Takahashi M; Yoshimura T; Muraille E; Philpott D; Schroeder JT; Hyodo M; Hayakawa Y; Talbot BG; Brouillette E; Malouin F J Immunol; 2007 Feb; 178(4):2171-81. PubMed ID: 17277122 [TBL] [Abstract][Full Text] [Related]
11. c-di-GMP (3'-5'-cyclic diguanylic acid) inhibits Staphylococcus aureus cell-cell interactions and biofilm formation. Karaolis DK; Rashid MH; Chythanya R; Luo W; Hyodo M; Hayakawa Y Antimicrob Agents Chemother; 2005 Mar; 49(3):1029-38. PubMed ID: 15728899 [TBL] [Abstract][Full Text] [Related]
12. Phosphate-dependent modulation of c-di-GMP levels regulates Pseudomonas fluorescens Pf0-1 biofilm formation by controlling secretion of the adhesin LapA. Monds RD; Newell PD; Gross RH; O'Toole GA Mol Microbiol; 2007 Feb; 63(3):656-79. PubMed ID: 17302799 [TBL] [Abstract][Full Text] [Related]
13. Monitoring of diguanylate cyclase activity and of cyclic-di-GMP biosynthesis by whole-cell assays suitable for high-throughput screening of biofilm inhibitors. Antoniani D; Bocci P; Maciag A; Raffaelli N; Landini P Appl Microbiol Biotechnol; 2010 Jan; 85(4):1095-104. PubMed ID: 19707751 [TBL] [Abstract][Full Text] [Related]
14. Thiazole orange-induced c-di-GMP quadruplex formation facilitates a simple fluorescent detection of this ubiquitous biofilm regulating molecule. Nakayama S; Kelsey I; Wang J; Roelofs K; Stefane B; Luo Y; Lee VT; Sintim HO J Am Chem Soc; 2011 Apr; 133(13):4856-64. PubMed ID: 21384923 [TBL] [Abstract][Full Text] [Related]
15. Multiple activities of c-di-GMP in Pseudomonas aeruginosa. Lory S; Merighi M; Hyodo M Nucleic Acids Symp Ser (Oxf); 2009; (53):51-2. PubMed ID: 19749255 [TBL] [Abstract][Full Text] [Related]
16. The cAMP receptor-like protein CLP is a novel c-di-GMP receptor linking cell-cell signaling to virulence gene expression in Xanthomonas campestris. Chin KH; Lee YC; Tu ZL; Chen CH; Tseng YH; Yang JM; Ryan RP; McCarthy Y; Dow JM; Wang AH; Chou SH J Mol Biol; 2010 Feb; 396(3):646-62. PubMed ID: 20004667 [TBL] [Abstract][Full Text] [Related]
17. C-di-GMP: the dawning of a novel bacterial signalling system. Römling U; Gomelsky M; Galperin MY Mol Microbiol; 2005 Aug; 57(3):629-39. PubMed ID: 16045609 [TBL] [Abstract][Full Text] [Related]
18. The role of c-di-GMP signaling in an Aeromonas veronii biovar sobria strain. Rahman M; Simm R; Kader A; Basseres E; Römling U; Möllby R FEMS Microbiol Lett; 2007 Aug; 273(2):172-9. PubMed ID: 17573931 [TBL] [Abstract][Full Text] [Related]
19. A new adjuvant delivery system 'cyclic di-GMP/YSK05 liposome' for cancer immunotherapy. Miyabe H; Hyodo M; Nakamura T; Sato Y; Hayakawa Y; Harashima H J Control Release; 2014 Jun; 184():20-7. PubMed ID: 24727060 [TBL] [Abstract][Full Text] [Related]
20. 3',5'-cyclic diguanylic acid reduces the virulence of biofilm-forming Staphylococcus aureus strains in a mouse model of mastitis infection. Brouillette E; Hyodo M; Hayakawa Y; Karaolis DK; Malouin F Antimicrob Agents Chemother; 2005 Aug; 49(8):3109-13. PubMed ID: 16048911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]